Home › Funds › ESSEX INVESTMENT MANAGEMENT CO LLC › NVCR
ESSEX INVESTMENT MANAGEMENT CO LLC position in NVCR
NOVOCURE LTD · Health Care
ESSEX INVESTMENT MANAGEMENT CO LLC reported holding 424,133 shares of NVCR (NOVOCURE LTD) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 1.01% of its reported portfolio and ranking #22 among its reported holdings. ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed NVCR holdings in 7 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How ESSEX INVESTMENT MANAGEMENT CO LLC's NVCR position evolved
ESSEX INVESTMENT MANAGEMENT CO LLC first disclosed a stake in NVCR in Q2 2024 at 161,486 shares (US$2.8M). The position peaked in Q3 2026 at 424,133 shares, worth US$6.8M. Across 7 filings, ESSEX INVESTMENT MANAGEMENT CO LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 424,133 shares valued at US$6.8M — a reduction of -15,515 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 161.49K | $2.77M | New |
| Q3 2024 | 161.94K | $2.53M | Hold |
| Q4 2024 | 121.83K | $3.63M | Reduce |
| Q1 2025 | 121.04K | $2.16M | Reduce |
| Q1 2026 | 452.37K | $4.93M | New |
| Q2 2026 | 439.65K | $6.66M | Reduce |
| Q3 2026 | 424.13K | $6.76M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVCR and 13F data
NVCR (NOVOCURE LTD) is a Health Care company. 32 other funds we track also report a position in NVCR — the largest reported positions include Soleus Capital Management, L.P. (US$150.2M), Palo Alto Investors LP (US$19.4M), C WorldWide Group Holding A/S (US$14.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVCR
- Soleus Capital Management, L.P. 9.91M sh · $150.19M · Q2 2026
- Palo Alto Investors LP 1.28M sh · $19.40M · Q2 2026
- C WorldWide Group Holding A/S 971.78K sh · $14.72M · Q2 2026
More on ESSEX INVESTMENT MANAGEMENT CO LLC
FAQ
How long has ESSEX INVESTMENT MANAGEMENT CO LLC held NVCR?
ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed NVCR holdings in 7 of the last 10 reported quarters, going back to Q2 2024.
What is ESSEX INVESTMENT MANAGEMENT CO LLC's current position in NVCR?
As of Q3 2026, ESSEX INVESTMENT MANAGEMENT CO LLC holds 424.13K shares of NVCR (NOVOCURE LTD), valued at $6.76M, representing 1.01% of its reported portfolio and ranking #22.
Has ESSEX INVESTMENT MANAGEMENT CO LLC been buying or selling NVCR?
In the latest 13F filing (Q3 2026), ESSEX INVESTMENT MANAGEMENT CO LLC reduced its position in NVCR. The position peaked in Q3 2026 at 424.13K shares.
Which other funds hold NVCR?
Other major institutional holders of NVCR include Soleus Capital Management, L.P., Palo Alto Investors LP, C WorldWide Group Holding A/S, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.